revealed that Nrf2 could also be modified by SUMOylation, which plays an important role in its transcriptional activity.[16] However, the key SUMO modification protein and enzyme that regulate the SUMOylation of Nrf2 and its role in ischemic stroke remain poorly understood. The gene discussed is NFE2L2; the disease is ischemic stroke.